Lv6
2436 积分 2024-01-02 加入
Response rates and survival to systemic therapy after immune checkpoint inhibitor failure in recurrent/metastatic head and neck squamous cell carcinoma
9小时前
待确认
Drug-induced skin toxicity: gaps in preclinical testing cascade as opportunities for complex in vitro models and assays
19小时前
待确认
Nimotuzumab: a novel anti-EGFR monoclonal antibody that retains anti-EGFR activity while minimizing skin toxicity
1天前
待确认
Rational identification of an optimal antibody mixture for targeting the epidermal growth factor receptor
4天前
已完结
Structural alterations of the epidermal growth factor receptor gene in human gliomas
4天前
已完结
Novel strategy for a bispecific antibody: induction of dual target internalization and degradation
4天前
已完结
Phase I Trial of Anti-MET Monoclonal Antibody in MET-Overexpressed Refractory Cancer
11天前
已完结
A Phase 2 study of Savolitinib in Patients with MET Amplified Metastatic Colorectal Cancer
11天前
已完结
The EGFR family and its ligands in human cancer
17天前
已完结
A phase 1b study of the MET inhibitor capmatinib combined with cetuximab in patients with MET-positive colorectal cancer who had progressed following anti-EGFR monoclonal antibody treatment
21天前
已完结
皖公网安备34019202002308
